Parisi Gray Wealth Management Buys 24 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Parisi Gray Wealth Management raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,591 shares of the healthcare conglomerate’s stock after purchasing an additional 24 shares during the quarter. UnitedHealth Group makes up about 1.4% of Parisi Gray Wealth Management’s investment portfolio, making the stock its 17th largest position. Parisi Gray Wealth Management’s holdings in UnitedHealth Group were worth $3,470,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kraft Davis & Associates LLC grew its stake in UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock valued at $294,000 after acquiring an additional 19 shares during the period. Iron Horse Wealth Management LLC grew its position in shares of UnitedHealth Group by 1.6% in the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares during the last quarter. Secure Asset Management LLC grew its position in UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after buying an additional 19 shares in the last quarter. Bensler LLC lifted its stake in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX boosted its holdings in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after acquiring an additional 19 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.3 %

NYSE UNH traded down $1.27 during mid-day trading on Thursday, hitting $491.83. The company’s stock had a trading volume of 311,961 shares, compared to its average volume of 4,038,452. The firm has a market capitalization of $453.43 billion, a P/E ratio of 20.68, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The stock’s fifty day simple moving average is $503.73 and its two-hundred day simple moving average is $518.79. UnitedHealth Group Incorporated has a 52-week low of $445.68 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter last year, the firm posted $5.34 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Barclays started coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective for the company. Bank of America reiterated a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a report on Thursday, February 29th. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Truist Financial restated a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Thursday, November 30th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $579.33.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.